Title:
MONTELUKAST SODIUM POLYMORPHS
Document Type and Number:
WIPO Patent Application WO2005075427
Kind Code:
A3
Abstract:
The present invention provides high crystallinity montelukast sodium, crystalline forms of montelukast sodium, and processes of preparing the same.
Inventors:
NIDDAM-HILDESHEIM VALERIE (IL)
ARONHIME JUDITH (IL)
STERIMBAUM GRETA (IL)
ARONHIME JUDITH (IL)
STERIMBAUM GRETA (IL)
Application Number:
PCT/US2005/002899
Publication Date:
October 06, 2005
Filing Date:
January 31, 2005
Export Citation:
Assignee:
TEVA PHARMA (US)
TEVA PHARMA (US)
NIDDAM-HILDESHEIM VALERIE (IL)
ARONHIME JUDITH (IL)
STERIMBAUM GRETA (IL)
TEVA PHARMA (US)
NIDDAM-HILDESHEIM VALERIE (IL)
ARONHIME JUDITH (IL)
STERIMBAUM GRETA (IL)
International Classes:
A61K31/47; C07D215/16; C07D215/18; (IPC1-7): C07D215/18; A61K31/47
Domestic Patent References:
| WO2004091618A1 | 2004-10-28 | |||
| WO2004108679A1 | 2004-12-16 |
Foreign References:
| US6320052B1 | 2001-11-20 |
Download PDF:
Previous Patent: SUBSTITUTED BISARYLUREA DERIVATIVES AS KINASE INHIBITORS
Next Patent: QUINOLINE DERIVATIVES FOR USE AS MYCOBACTERIAL INHIBITORS
Next Patent: QUINOLINE DERIVATIVES FOR USE AS MYCOBACTERIAL INHIBITORS